JEFFREY HALE: Open Payments
NPI 1437836145 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,944 in 209 payments from 17 companies in 2025. Trend: 2023 $76 · 2024 $1,731 · 2025 $2,944
Food & beverage: $2,931Education: $13
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 48 | $478 |
| ABBVIE INC. | 26 | $416 |
| Incyte Corporation | 25 | $390 |
| Verrica Pharmaceuticals Inc. | 27 | $260 |
| Janssen Biotech, Inc. | 22 | $258 |
| GENZYME CORPORATION | 10 | $236 |
| Amgen Inc. | 10 | $184 |
| Lilly USA, LLC | 12 | $171 |
| Organon LLC | 12 | $169 |
| Galderma Laboratories, L.P. | 4 | $107 |
Products named: Zoryve, SKYRIZI, OPZELURA, DUPIXENT, TREMFYA, YCANTH, OTEZLA, TALTZ.
Industry payments across CA — which companies pay providers there.
